Novo Nordisk to halve US list price of Wegovy from 2027 - Reuters
Novo Nordisk to halve US list price of Wegovy from 2027 Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxNVTFMTVV0MFRtVjF5ZXlEbDBFR0NaZzdfVFVpRUViMllpOV9hZjJEY2lrY0VBbVJBQ015XzBKSHNDMm9uNzB3UkE3VlJUcGRkQlNGM3VOdnRyekp0NXY3MHhUNklnS0ctVnJJSlp1YnhGZlB2ajBOOU5WckJmWVA0NkdWbWNZNmtrTk1OSG9Rc0JvQUpGSUhCMmpmQXR0NUdJNUtPVHV5SGk5RUY0V19HX1ZwcXFDSWtKN3RseGZXMmI4QVdxS2JrdFZHYi0?oc=5" target="_blank">Novo Nordisk to halve US list price of Wegovy from 2027</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMTeva wins FDA approval for monthly schizophrenia injection Weltruza - Reuters
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
October 9, 2026 at 11:47 AMWHO endorses lifestyle changes over GLP-1 drugs in child obesity fight - Reuters
WHO endorses lifestyle changes over GLP-1 drugs in child obesity fight Reuters
October 7, 2026 at 07:39 AMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMPharma lobby sues Trump administration over Medicare drug price cuts - Reuters
Pharma lobby sues Trump administration over Medicare drug price cuts Reuters
October 7, 2026 at 05:08 PMUS FDA expands use of Novartis drug for chronic skin condition - Reuters
US FDA expands use of Novartis drug for chronic skin condition Reuters
October 7, 2026 at 04:51 PM